12
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Sex and Gender in Neurodegenerative Diseases

      Submit here before September 30, 2024

      About Neurodegenerative Diseases: 3.0 Impact Factor I 4.3 CiteScore I 0.695 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Homocysteine as a Risk Factor for Ischemic Stroke: An Epidemiological Story in Evolution

      review-article
      , ,
      Neuroepidemiology
      S. Karger AG
      Cerebrovascular disorders, Homocysteine, Risk factor

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: not found
          • Article: not found

          Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men

            Bookmark

            Author and article information

            Journal
            NED
            Neuroepidemiology
            10.1159/issn.0251-5350
            Neuroepidemiology
            S. Karger AG
            0251-5350
            1423-0208
            1998
            August 1998
            10 July 1998
            : 17
            : 4
            : 167-173
            Affiliations
            The Neurological Institute, Departments of Neurology and Public Health (Epidemiology) and the Sergievsky Center, Columbia Presbyterian Medical Center, New York, N.Y., USA
            Article
            26169 Neuroepidemiology 1998;17:167–173
            10.1159/000026169
            9701830
            2520d061-ecef-40c8-99ec-587681cf3871
            © 1998 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            History
            Page count
            Pages: 7
            Categories
            Invited Review

            Geriatric medicine,Neurology,Cardiovascular Medicine,Neurosciences,Clinical Psychology & Psychiatry,Public health
            Risk factor,Cerebrovascular disorders,Homocysteine

            Comments

            Comment on this article